Related Experiment Video
Updated: Aug 20, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Impact of ventilator-associated pneumonia in patients with severe head injury
M Dolores Rincón-Ferrari1, Juan M Flores-Cordero, S Ramón Leal-Noval
1Critical Care and Emergency Department, University Hospital Virgen del Rocío, Seville, Spain. marilorincon@hotmail.com
Background:
The impact of ventilator-associated pneumonia (VAP) on outcome seems to vary depending on the critically ill patients we analyze. Our objective, therefore, has been to evaluate the influence of VAP on the mortality and morbidity in patients with severe head injury (Glasgow Coma Scale score = 8).
Methods:
A prospective, matched, case-control study was conducted in our intensive care unit (ICU) for a 3-year period (1998-2000). Seventy-two patients with severe head injury (HI) who developed VAP were matched with 72 patients with severe HI without VAP. The matching criteria were as follows: age (+/- 5 years); category of HI based on computed tomographic scanning; Acute Physiology and Chronic Health Evaluation II (+/- 4 points) score; Injury Severity Score (+/- 4 points); and duration of mechanical ventilation. VAP was diagnosed on the basis of quantitative microbiologic criteria.
Results:
Mortality did not differ significantly between cases and matched control subjects (15 [20.8%] vs. 11 [15.3%], p = 0.54). However, patients with VAP had a significantly longer duration of mechanical ventilation (median, 14 vs. 10 days; p = 0.015) and ICU stay (median, 21 vs. 15.5 days; p = 0.008). The occurrence of multiple organ failure was also significantly more frequent among the case group (33.3% vs. 12.5%, p = 0.004) during the overall ICU stay.
Conclusion:
VAP does not seem to be associated with a significantly increased risk of death in patients with severe HI, but it may be associated with greater morbidity during the ICU stay.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Pneumonia III: Complications and Assessment
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
